These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9585798)

  • 1. Can bioavailability of low-variance drugs be estimated with an unpaired, sparse sampling design?
    Wright PM; Fisher DM
    Clin Pharmacol Ther; 1998 Apr; 63(4):437-43. PubMed ID: 9585798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
    Variol P; Nguyen L; Tranchand B; Puozzo C
    Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods.
    Jaki T; Wolfsegger MJ; Ploner M
    Pharm Stat; 2009; 8(1):12-24. PubMed ID: 18407562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A random sampling approach for robust estimation of tissue-to-plasma ratio from extremely sparse data.
    Chu HM; Ette EI
    AAPS J; 2005 Sep; 7(1):E249-58. PubMed ID: 16146346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of nonlinear mixed effect modeling for the meta-analysis of preclinical pharmacokinetic data: application to S 20342 in the rat.
    Bouzom F; Laveille C; Merdjan H; Jochemsen R
    J Pharm Sci; 2000 May; 89(5):603-13. PubMed ID: 10756326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear mixed effects to improve glucose minimal model parameter estimation: a simulation study in intensive and sparse sampling.
    Denti P; Bertoldo A; Vicini P; Cobelli C
    IEEE Trans Biomed Eng; 2009 Sep; 56(9):2156-66. PubMed ID: 19380266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in analyzing single-trough concentrations using mixed-effects modeling.
    Booth BP; Gobburu JV
    J Clin Pharmacol; 2003 Dec; 43(12):1307-15. PubMed ID: 14615466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
    Panhard X; Mentré F
    Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of an optimal sampling strategy for meropenem in febrile neutropenics.
    Ariano RE; Zelenitsky SA; Nyhlén A; Sitar DS
    J Clin Pharmacol; 2005 Jul; 45(7):832-5. PubMed ID: 15951473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sampling regime on the mean and variance of home range size estimates.
    Börger L; Franconi N; De Michele G; Gantz A; Meschi F; Manica A; Lovari S; Coulson T
    J Anim Ecol; 2006 Nov; 75(6):1393-405. PubMed ID: 17032372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic parameter estimation: population size versus number of samples.
    Girgis S; Pai SM; Girgis IG; Batra VK
    AAPS J; 2005 Oct; 7(2):46. PubMed ID: 16353905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive versus electrotransport-facilitated transdermal absorption of ketorolac.
    Park K; Verotta D; Gupta SK; Sheiner LB
    Clin Pharmacol Ther; 1998 Mar; 63(3):303-15. PubMed ID: 9542474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.